Results 241 to 250 of about 3,831,493 (359)
Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy
Objective Exenatide, a glucagon‐like peptide‐1 (GLP‐1) receptor agonist, has neuroprotective effects in preclinical models of multiple system atrophy (MSA). We investigated these effects in a proof‐of‐concept clinical trial. Methods In this single‐center, randomized, open label trial, participants with MSA were randomly assigned (1:1) to receive ...
Nirosen Vijiaratnam +29 more
wiley +1 more source
The mediating role of attachment in panic disorder and separation anxiety disorder. [PDF]
Baltacioğlu M +2 more
europepmc +1 more source
Depression Polygenicity and Disease Activity and Disability Worsening in Multiple Sclerosis
Objective A better understanding of factors associated with multiple sclerosis (MS) disease activity and disability is needed. Given the strong link between comorbid depression and MS disease activity and disability, we aimed to determine whether the depression genetic burden, as modelled using its polygenic score, is associated with MS disease ...
Ali Manouchehrinia +24 more
wiley +1 more source
Symptom Attributions in Illness Anxiety Disorder. [PDF]
Holden ML +6 more
europepmc +1 more source
Objective Mutations in TARDBP (encoding TDP‐43) are associated with the neurodegenerative disease amyotrophic lateral sclerosis (ALS) and include familial missense mutations where there are a lack of models and mechanisms examining how they are pathogenic.
Ziyaan A. Harji +10 more
wiley +1 more source
Parental rejection and generalized anxiety disorder in early adolescents: the mediating role of alexithymia. [PDF]
Fabris MA +3 more
europepmc +1 more source

